Our results show that mTOR and GSK3β signaling was profoundly altered in the chronic depression model used in this study, and that fluoxetine reversed in part these alterations in normal mice but not in OCT2 mutants. The gene discussed is SLC22A2; the disease is depressive symptom measurement.